Imaging is of major clinical importance in the noninvasive evaluation and m
anagement of patients with cancer. Computed tomography (CT) and other anato
mic imaging modalities, such as magnetic resonance imaging (MRI) or ultraso
und, have a high diagnostic ability by visualizing lesion morphology and by
providing the exact localization of malignant sites. Nuclear medicine prov
ides information on the function and metabolism of cancer. Over the last de
cade, there have been numerous attempts to combine data obtained from diffe
rent imaging techniques. Fused images of nuclear medicine and CT (or to a l
esser extent, MRI) overcome the inherent limitations of both modalities. Va
luable physiologic information benefits from a precise topographic localiza
tion. Coregistered data have been shown to be useful in the evaluation of p
atients with cancer at diagnosis and staging, in monitoring the response to
treatment, and during follow up, for early detection of recurrence. Time-c
onsuming and difficult realignment and computation for fusion of independen
t studies have, until now, limited the use of registration techniques to pi
lot studies performed in a small number of patients. The development of the
new technology of single photon emission computed tomography/CT and positr
on emission tomography/CT that allows for combined functional and anatomic
data acquisition has the potential to make fusion an everyday clinical tool
. Copyright (C) 2001 by W.B. Saunders Company.